The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Sprycel-Global Market Insights and Sales Trends 2025
Synopsis
Dasatinib, sold under the brand name Sprycel, is a chemotherapy medication used to treat certain cases of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL).
The global Sprycel market size is expected to reach US$ 514.6 million by 2029, growing at a CAGR of 8.4% from 2023 to 2029. The market is mainly driven by the significant applications of Sprycel in various end use industries. The expanding demands from the CML and ALL, are propelling Sprycel market. 20mg, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 50mg segment is estimated at % CAGR for the next seven-year period.
Sprycel received regulatory approvals for use in CML and Ph+ ALL in various countries, expanding its market reach and availability.
Recommendations from medical societies and clinical guidelines regarding the use of Sprycel in specific patient populations can influence its demand.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Sprycel, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Sprycel market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Sprycel market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Sprycel sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Sprycel covered in this report include Bristol-Myers Squibb and LUCIUS Pharma etc.
The global Sprycel market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bristol-Myers Squibb
LUCIUS Pharma
Global Sprycel market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Sprycel market, Segment by Type:
20mg
50mg
70mg
Global Sprycel market, by Application
CML
ALL
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Sprycel manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Sprycel in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Dasatinib, sold under the brand name Sprycel, is a chemotherapy medication used to treat certain cases of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL).
The global Sprycel market size is expected to reach US$ 514.6 million by 2029, growing at a CAGR of 8.4% from 2023 to 2029. The market is mainly driven by the significant applications of Sprycel in various end use industries. The expanding demands from the CML and ALL, are propelling Sprycel market. 20mg, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 50mg segment is estimated at % CAGR for the next seven-year period.
Sprycel received regulatory approvals for use in CML and Ph+ ALL in various countries, expanding its market reach and availability.
Recommendations from medical societies and clinical guidelines regarding the use of Sprycel in specific patient populations can influence its demand.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Sprycel, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Sprycel market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Sprycel market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Sprycel sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Sprycel covered in this report include Bristol-Myers Squibb and LUCIUS Pharma etc.
The global Sprycel market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bristol-Myers Squibb
LUCIUS Pharma
Global Sprycel market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Sprycel market, Segment by Type:
20mg
50mg
70mg
Global Sprycel market, by Application
CML
ALL
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Sprycel manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Sprycel in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Sprycel Market Overview
1.1 Sprycel Product Overview
1.2 Sprycel Market Segment by Type
1.2.1 20mg
1.2.2 50mg
1.2.3 70mg
1.3 Global Sprycel Market Size by Type
1.3.1 Global Sprycel Market Size Overview by Type (2018-2029)
1.3.2 Global Sprycel Historic Market Size Review by Type (2018-2023)
1.3.3 Global Sprycel Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Sprycel Sales Breakdown by Type (2018-2023)
1.4.2 Europe Sprycel Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Sprycel Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Sprycel Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Sprycel Sales Breakdown by Type (2018-2023)
2 Global Sprycel Market Competition by Company
2.1 Global Top Players by Sprycel Sales (2018-2023)
2.2 Global Top Players by Sprycel Revenue (2018-2023)
2.3 Global Top Players by Sprycel Price (2018-2023)
2.4 Global Top Manufacturers Sprycel Manufacturing Base Distribution, Sales Area, Product Type
2.5 Sprycel Market Competitive Situation and Trends
2.5.1 Sprycel Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Sprycel Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sprycel as of 2022)
2.7 Date of Key Manufacturers Enter into Sprycel Market
2.8 Key Manufacturers Sprycel Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Sprycel Status and Outlook by Region
3.1 Global Sprycel Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Sprycel Historic Market Size by Region
3.2.1 Global Sprycel Sales in Volume by Region (2018-2023)
3.2.2 Global Sprycel Sales in Value by Region (2018-2023)
3.2.3 Global Sprycel Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Sprycel Forecasted Market Size by Region
3.3.1 Global Sprycel Sales in Volume by Region (2024-2029)
3.3.2 Global Sprycel Sales in Value by Region (2024-2029)
3.3.3 Global Sprycel Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Sprycel by Application
4.1 Sprycel Market Segment by Application
4.1.1 CML
4.1.2 ALL
4.2 Global Sprycel Market Size by Application
4.2.1 Global Sprycel Market Size Overview by Application (2018-2029)
4.2.2 Global Sprycel Historic Market Size Review by Application (2018-2023)
4.2.3 Global Sprycel Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Sprycel Sales Breakdown by Application (2018-2023)
4.3.2 Europe Sprycel Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Sprycel Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Sprycel Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Sprycel Sales Breakdown by Application (2018-2023)
5 North America Sprycel by Country
5.1 North America Sprycel Historic Market Size by Country
5.1.1 North America Sprycel Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Sprycel Sales in Volume by Country (2018-2023)
5.1.3 North America Sprycel Sales in Value by Country (2018-2023)
5.2 North America Sprycel Forecasted Market Size by Country
5.2.1 North America Sprycel Sales in Volume by Country (2024-2029)
5.2.2 North America Sprycel Sales in Value by Country (2024-2029)
6 Europe Sprycel by Country
6.1 Europe Sprycel Historic Market Size by Country
6.1.1 Europe Sprycel Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Sprycel Sales in Volume by Country (2018-2023)
6.1.3 Europe Sprycel Sales in Value by Country (2018-2023)
6.2 Europe Sprycel Forecasted Market Size by Country
6.2.1 Europe Sprycel Sales in Volume by Country (2024-2029)
6.2.2 Europe Sprycel Sales in Value by Country (2024-2029)
7 Asia-Pacific Sprycel by Region
7.1 Asia-Pacific Sprycel Historic Market Size by Region
7.1.1 Asia-Pacific Sprycel Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Sprycel Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Sprycel Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Sprycel Forecasted Market Size by Region
7.2.1 Asia-Pacific Sprycel Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Sprycel Sales in Value by Region (2024-2029)
8 Latin America Sprycel by Country
8.1 Latin America Sprycel Historic Market Size by Country
8.1.1 Latin America Sprycel Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Sprycel Sales in Volume by Country (2018-2023)
8.1.3 Latin America Sprycel Sales in Value by Country (2018-2023)
8.2 Latin America Sprycel Forecasted Market Size by Country
8.2.1 Latin America Sprycel Sales in Volume by Country (2024-2029)
8.2.2 Latin America Sprycel Sales in Value by Country (2024-2029)
9 Middle East and Africa Sprycel by Country
9.1 Middle East and Africa Sprycel Historic Market Size by Country
9.1.1 Middle East and Africa Sprycel Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Sprycel Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Sprycel Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Sprycel Forecasted Market Size by Country
9.2.1 Middle East and Africa Sprycel Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Sprycel Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Bristol-Myers Squibb
10.1.1 Bristol-Myers Squibb Company Information
10.1.2 Bristol-Myers Squibb Introduction and Business Overview
10.1.3 Bristol-Myers Squibb Sprycel Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bristol-Myers Squibb Sprycel Products Offered
10.1.5 Bristol-Myers Squibb Recent Development
10.2 LUCIUS Pharma
10.2.1 LUCIUS Pharma Company Information
10.2.2 LUCIUS Pharma Introduction and Business Overview
10.2.3 LUCIUS Pharma Sprycel Sales, Revenue and Gross Margin (2018-2023)
10.2.4 LUCIUS Pharma Sprycel Products Offered
10.2.5 LUCIUS Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Sprycel Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Sprycel Industrial Chain Analysis
11.4 Sprycel Market Dynamics
11.4.1 Sprycel Industry Trends
11.4.2 Sprycel Market Drivers
11.4.3 Sprycel Market Challenges
11.4.4 Sprycel Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Sprycel Distributors
12.3 Sprycel Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
